Long-term benefits of rituximab (anti-CD20) for refractory systemic lupus erythematosus Y. Tanaka, M. Tokunaga,M. Nawata,K. Suzuki,S. Iwata,K. Yamaoka,S. Nakayamada,K. SaitoANNALS OF THE RHEUMATIC DISEASES(2007)引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要